Industry: Chemical & Material
Published Date: 2026-01-05
Pages: 94 Pages
Report ld: 5508494
Request Sample
Customized Report
Imazapyr Market Size(US$)

CAGR 2026-2032
4.7%
Market Size,2032
USD 186
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Imazapyr was estimated to be worth US$ 135 million in 2025 and is projected to reach US$ 186 million, growing at a CAGR of 4.7% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Imazapyr cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Imazapyr is a systemic, non-selective herbicide widely used in agriculture, forestry, and land management to control a broad spectrum of weeds, woody plants, and grasses. Chemically classified as an imidazolinone, it has the molecular formula C13H15N3O3 and is known for its effectiveness at low application rates. Imazapyr is valued for its broad-spectrum activity and long-lasting soil residual effects, making it a preferred choice for managing invasive species and maintaining areas free of undesirable vegetation.
Imazapyr works by inhibiting the enzyme acetolactate synthase (ALS), also known as acetohydroxyacid synthase (AHAS). ALS is crucial in plants for synthesizing branched-chain amino acids such as isoleucine, leucine, and valine. When imazapyr disrupts this enzyme, the target plants experience halted growth and eventual death due to amino acid deficiency. Because animals do not possess ALS, imazapyr is considered relatively low in toxicity to mammals and other non-target organisms when used according to label directions.
One of the key benefits of imazapyr is its persistence in the soil, allowing long-term control of unwanted vegetation. It is also effective at low doses, reducing the quantity of chemical needed per application. Moreover, imazapyr demonstrates minimal leaching potential in certain soil types, which reduces the likelihood of groundwater contamination under appropriate usage.
Despite its advantages, imazapyr has notable environmental considerations. It is highly mobile in the environment, especially in sandy soils, and can potentially affect non-target plants through root uptake or drift during application. To minimize unintended harm, careful adherence to buffer zones and application guidelines is essential.
Imazapyr is an organic heterocyclic herbicide developed by the American Cyanamid Company. It is a lethal herbicide. Its isopropylamine salt can be used before or after germination. It can be quickly absorbed by the roots and leaves of cultivated weeds, inhibiting the biosynthesis of the side chain amino acids of cultivated weeds, preventing the growth of weeds and causing them to die. The control targets include all weeds, and it has good weed control activity against sedge weeds, annual and perennial monocotyledonous weeds, broad-leaved weeds and miscellaneous woods. It is suitable for non-cultivated land as well as rubber plantations, oil palm, forests and tea gardens.
Rapid urbanization and the need to maintain clear zones along transport and utility corridors drive the demand for herbicides like imazapyr.
Growing environmental awareness and initiatives to control invasive plants support the use of imazapyr in both terrestrial and aquatic ecosystems.
Imazapyr’s ability to provide long-lasting control at low application rates makes it an economically viable option for large-scale vegetation management.
Global key players of imazapyr include CYNDA, BASF, Rainbow, etc. China is the largest producer of imazapyr holds a share over 60%. In terms of application, the largest application is farmland weeding, with a share over 70%.
This report provides a comprehensive view of the global market for Imazapyr, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Imazapyr market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Imazapyr.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Imazapyr manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Imazapyr sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Imazapyr sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Imazapyr Product Introduction
1.2 Global Imazapyr Market Size Forecast
1.2.1 Global Imazapyr Sales Value (2021–2032)
1.2.2 Global Imazapyr Sales Volume (2021–2032)
1.2.3 Global Imazapyr Sales Price (2021–2032)
1.3 Imazapyr Market Trends & Drivers
1.3.1 Imazapyr Industry Trends
1.3.2 Imazapyr Market Drivers & Opportunities
1.3.3 Imazapyr Market Challenges
1.3.4 Imazapyr Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Imazapyr Players Revenue Ranking (2025)
2.2 Global Imazapyr Revenue by Company (2021–2026)
2.3 Global Imazapyr Sales Volume Ranking of Players (2025)
2.4 Global Imazapyr Sales Volume by Company (2021–2026)
2.5 Global Imazapyr Average Price by Company (2021–2026)
2.6 Key Manufacturers Imazapyr Manufacturing Base and Headquarters
2.7 Key Manufacturers Imazapyr Product Offerings
2.8 Key Manufacturers Start of Mass Production of Imazapyr
2.9 Imazapyr Market Competitive Analysis
2.9.1 Imazapyr Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Imazapyr Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Imazapyr revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Imazapyr Market Classification
3.1 Introduction by Type
3.1.1 Content 98%
3.1.2 Content 95%
3.1.3 Others
3.1.4 Global Imazapyr Sales Value by Type
3.1.4.1 Global Imazapyr Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Imazapyr Sales Value, by Type (2021–2032)
3.1.4.3 Global Imazapyr Sales Value, by Type (%), 2021–2032
3.1.5 Global Imazapyr Sales Volume by Type
3.1.5.1 Global Imazapyr Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Imazapyr Sales Volume, by Type (2021–2032)
3.1.5.3 Global Imazapyr Sales Volume, by Type (%), 2021–2032
3.1.6 Global Imazapyr Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Farmland Weeding
4.1.2 Non-arable Weeding
4.2 Global Imazapyr Sales Value by Application
4.2.1 Global Imazapyr Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Imazapyr Sales Value, by Application (2021–2032)
4.2.3 Global Imazapyr Sales Value, by Application (%), 2021–2032
4.3 Global Imazapyr Sales Volume by Application
4.3.1 Global Imazapyr Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Imazapyr Sales Volume, by Application (2021–2032)
4.3.3 Global Imazapyr Sales Volume, by Application (%), 2021–2032
4.4 Global Imazapyr Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Imazapyr Sales Value by Region
5.1.1 Global Imazapyr Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Imazapyr Sales Value by Region (2021–2026)
5.1.3 Global Imazapyr Sales Value by Region (2027–2032)
5.1.4 Global Imazapyr Sales Value by Region (%), 2021–2032
5.2 Global Imazapyr Sales Volume by Region
5.2.1 Global Imazapyr Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Imazapyr Sales Volume by Region (2021–2026)
5.2.3 Global Imazapyr Sales Volume by Region (2027–2032)
5.2.4 Global Imazapyr Sales Volume by Region (%), 2021–2032
5.3 Global Imazapyr Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Imazapyr Sales Value, 2021–2032
5.4.2 North America Imazapyr Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Imazapyr Sales Value, 2021–2032
5.5.2 Europe Imazapyr Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Imazapyr Sales Value, 2021–2032
5.6.2 Asia Pacific Imazapyr Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Imazapyr Sales Value, 2021–2032
5.7.2 South America Imazapyr Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Imazapyr Sales Value, 2021–2032
5.8.2 Middle East & Africa Imazapyr Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Imazapyr Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Imazapyr Sales Value and Sales Volume
6.2.1 Key Countries/Regions Imazapyr Sales Value, 2021–2032
6.2.2 Key Countries/Regions Imazapyr Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Imazapyr Sales Value, 2021–2032
6.3.2 United States Imazapyr Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Imazapyr Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Imazapyr Sales Value, 2021–2032
6.4.2 Europe Imazapyr Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Imazapyr Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Imazapyr Sales Value, 2021–2032
6.5.2 China Imazapyr Sales Value by Type (%), 2025 vs 2032
6.5.3 China Imazapyr Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Imazapyr Sales Value, 2021–2032
6.6.2 Japan Imazapyr Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Imazapyr Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Imazapyr Sales Value, 2021–2032
6.7.2 South Korea Imazapyr Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Imazapyr Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Imazapyr Sales Value, 2021–2032
6.8.2 Southeast Asia Imazapyr Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Imazapyr Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Imazapyr Sales Value, 2021–2032
6.9.2 India Imazapyr Sales Value by Type (%), 2025 vs 2032
6.9.3 India Imazapyr Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 CYNDA
7.1.1 CYNDA Company Information
7.1.2 CYNDA Introduction and Business Overview
7.1.3 CYNDA Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 CYNDA Imazapyr Product Offerings
7.1.5 CYNDA Recent Developments
7.2 BASF
7.2.1 BASF Company Information
7.2.2 BASF Introduction and Business Overview
7.2.3 BASF Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 BASF Imazapyr Product Offerings
7.2.5 BASF Recent Developments
7.3 Rainbow
7.3.1 Rainbow Company Information
7.3.2 Rainbow Introduction and Business Overview
7.3.3 Rainbow Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Rainbow Imazapyr Product Offerings
7.3.5 Rainbow Recent Developments
7.4 Jiangsu Agrochem Laboratory
7.4.1 Jiangsu Agrochem Laboratory Company Information
7.4.2 Jiangsu Agrochem Laboratory Introduction and Business Overview
7.4.3 Jiangsu Agrochem Laboratory Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Jiangsu Agrochem Laboratory Imazapyr Product Offerings
7.4.5 Jiangsu Agrochem Laboratory Recent Developments
7.5 SIPCAM
7.5.1 SIPCAM Company Information
7.5.2 SIPCAM Introduction and Business Overview
7.5.3 SIPCAM Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 SIPCAM Imazapyr Product Offerings
7.5.5 SIPCAM Recent Developments
7.6 ADAMA
7.6.1 ADAMA Company Information
7.6.2 ADAMA Introduction and Business Overview
7.6.3 ADAMA Imazapyr Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 ADAMA Imazapyr Product Offerings
7.6.5 ADAMA Recent Developments
8 Industry Chain Analysis
8.1 Imazapyr Industrial Chain
8.2 Imazapyr Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Imazapyr Sales Model
8.5.2 Sales Channels
8.5.3 Imazapyr Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Imazapyr market size was US$ 135 million in 2025 and is forecast to reach a readjusted size of US$ 186 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 77
USD 4250.00
(Single User License)
The global Imazapyr market was valued at US$ 135 million in 2025 and is anticipated to reach US$ 186 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 134
USD 2900.00
(Single User License)
The global Imazapyr market size was US$ 130 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 79
USD 4250.00
(Single User License)
The global Imazapyr market is projected to grow from US$ 130 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 133
USD 4900.00
(Single User License)
The global market for Imazapyr was valued at US$ 130 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-02-09
Pages: 86
USD 2900.00
(Single User License)
The global market for Imazapyr was estimated to be worth US$ 130 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 108
USD 3950.00
(Single User License)
The global Imazapyr revenue was US$ 125 million in 2023 and is forecast to a readjusted size of US$ 171 million by 2030 with a CAGR of 4.7% during the review period (2024-2030).
Published Date: 2024-12-03
Pages: 111
USD 4350.00
(Single User License)
The global market for Imazapyr was estimated to be worth US$ 125 million in 2023 and is forecast to a readjusted size of US$ 171 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030.
Published Date: 2024-12-03
Pages: 104
USD 3950.00
(Single User License)
Valued at US$ 130 million in 2024, the global Imazapyr market is forecast to reach US$ 171 million by 2030, at a CAGR of 4.7% during the forecast period.
Published Date: 2024-12-03
Pages: 141
USD 4900.00
(Single User License)
The global market for Imazapyr was valued at US$ 125 million in the year 2023 and is projected to reach a revised size of US$ 171 million by 2030, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2024-12-03
Pages: 94
USD 2900.00
(Single User License)
The global Imazapyr market size was US$ 135 million in 2025 and is forecast to reach a readjusted size of US$ 186 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 77
The global Imazapyr market was valued at US$ 135 million in 2025 and is anticipated to reach US$ 186 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 134
The global Imazapyr market size was US$ 130 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 79
The global Imazapyr market is projected to grow from US$ 130 million in 2024 to US$ 178 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 133
The global market for Imazapyr was valued at US$ 130 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-02-09
Pages: 86
The global market for Imazapyr was estimated to be worth US$ 130 million in 2024 and is forecast to a readjusted size of US$ 178 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 108
The global Imazapyr revenue was US$ 125 million in 2023 and is forecast to a readjusted size of US$ 171 million by 2030 with a CAGR of 4.7% during the review period (2024-2030).
Published: 2024-12-03
Pages: 111
The global market for Imazapyr was estimated to be worth US$ 125 million in 2023 and is forecast to a readjusted size of US$ 171 million by 2030 with a CAGR of 4.7% during the forecast period 2024-2030.
Published: 2024-12-03
Pages: 104
Valued at US$ 130 million in 2024, the global Imazapyr market is forecast to reach US$ 171 million by 2030, at a CAGR of 4.7% during the forecast period.
Published: 2024-12-03
Pages: 141
The global market for Imazapyr was valued at US$ 125 million in the year 2023 and is projected to reach a revised size of US$ 171 million by 2030, growing at a CAGR of 4.7% during the forecast period.
Published: 2024-12-03
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now